Dr. Moschcovich
Pharmaceuticals
Pfizer
Bahamas
Biography
Dr. Laura Moschcovich joined OPKO Biologics (formerly Prolor Biotech) in 2007 as the Head of Downstream Development, leading the development of the purification process of MOD-4023 (CTP-growth hormone). In 2012 she became Project Manager responsible for overseeing three different projects in collaboration with different CMOs, taking the responsibility of the technology transfer of the pr
Research Interest
Lipidology, Vascular biology, Immunology
